TC10 Automated Counter’s Successor Offers Reliable Mammalian Cell Counts in 30 Seconds
Hercules, CA — September 17, 2012—Bio-Rad Laboratories, Inc. today announced the launch of its TC20 automated cell counter, the next generation of the company’s TC10™ automated cell counter that provides accurate and reliable counts of live mammalian cells in 30 seconds. The TC20 system’s improved lens and cell counting algorithm make it compatible with a broader range of cell sizes and types. This includes cells smaller than 10 microns and complex samples such as stem cells and primary cells derived from tissue or blood.
Stem cell research, toxicology studies, and flow cytometry all rely on an accurate and consistent number of input cells. Counting cells prior to cell culture or before starting processes and analytical techniques used in such work is extremely tedious if done manually with a hemocytometer. Manually counting cells is also subject to user bias, which can lead to variable results among researchers.
Many of the advanced features of the TC10 system, such as the auto-focus technology that provides highly reproducible cell counts with reduced user-to-user variability, remain in the TC20 system. The TC20 also has the ability to analyze cells across multiple focal planes, which eliminates live cell undercounting associated with single focal plane analysis. And unlike electrical impedance-based counters, researchers can view cells in real time to immediately confirm their total and live/dead cell counts.
Additional features new to the TC20 automated cell counter include:
- Cell size gates — enable accurate counting of such complex samples as primary cells, which are composed of multiple cell populations
- TC20 data analyzer — offers post-count analysis, such as histograms, and comparative analysis with multiple samples and reporting
- Automated data export — lets the user export count data to a USB flash drive to be analyzed using the TC20 data analyzer
Although the TC10 is no longer available, the counting slides, trypan blue dye, thermal printer, and verification kit developed for that system are compatible with the TC20 system.
Visit http://bit.ly/OTbe0s to see how the TC20 automated cell counter works. For more information on Bio-Rad’s product portfolio, please visit www.biorad.com/tc20.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 7,100 people globally and had revenues exceeding $2 billion in 2011. For more information, visit www.bio-rad.com.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.
For more information contact:
Steve Kulisch
Bio-Rad Laboratories, Inc.
510-741-5638
Steve_Kulisch@bio-rad.com
Ken Li
Chempetitive Group
312-997-2436 x 112
kli@chempetitive.com